Literature DB >> 16084426

Third Annual Mario S. Verani, MD, Memorial Lecture: The future of clinical nuclear cardiology.

Frans J Th Wackers1.   

Abstract

It is a great honor and privilege to present the Third Annual Mario S. Verani, MD, Memorial Lecture. Mario Verani (1943-2001) will be remembered foremost for his major contributions to the field of nuclear cardiology (Figure 1). For instance, he was one of the first investigators to recognize that fixed thallium defects were often not just scar but could be reversed by coronary revascularization. This led to an extensive revision of accepted traditional concepts on the meaning of image patterns. Mario's work on risk stratification by myocardial perfusion and function imaging after acute myocardial infarction was equally pioneering. He also laid out the basic principles for the safe use of adenosine for pharmacologic stress testing. Adenosine is now the preferred procedure all over the world in millions of patients. Dr Verani was a founding member and past president (1996-1997) of the American Society of Nuclear Cardiology (ASNC). The day before he died, he received the ASNC Distinguished Service Award. Personally, I will remember Mario as a very dear friend. We spent many hours together at meetings and gatherings all over the world. I still miss his outgoing personality, his warmth, his humor, and his enthusiasm. Above all, I enjoyed his comfortable friendship. That this friendship extended itself naturally to our wives, Regina and Marjan, made it all the more special. One of the best times we had was during a cardiology meeting in Recife, in the country of his birth, Brazil. I was greatly amused and, at the same time, impressed by the admiration and respect bestowed on him by his fellow Brazilians. One evening, we were going some place in the street on foot. We could not walk down the street without Mario being stopped by one or another Brazilian cardiologist who wanted to speak and consult with him. He was clearly greatly admired and appreciated in his country. I jokingly called him "King of Recife," and the king was holding audience. We arrived rather late where we were going... . I will always cherish the memories of our times together. I am grateful that I could visit Mario at his sickbed on the day before he passed away. He was so fragile and, at the same time, so courageous. I felt sad that there was so much that we could have discussed that we did not. Life seems sometimes full of missed opportunities... .

Entities:  

Mesh:

Year:  2005        PMID: 16084426     DOI: 10.1016/j.nuclcard.2005.05.004

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  35 in total

Review 1.  Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction.

Authors:  R J Gibbons; T D Miller; T F Christian
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Quantification of SPECT myocardial perfusion images: methodology and validation of the Yale-CQ method.

Authors:  Y H Liu; A J Sinusas; P DeMan; B L Zaret; F J Wackers
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

3.  Noninvasive coronary imaging and assessment of left ventricular function using 16-slice computed tomography.

Authors:  Joanne D Schuijf; Jeroen J Bax; Liesbeth P Salm; J Wouter Jukema; Hildo J Lamb; Ernst E van der Wall; Albert de Roos
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

4.  Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities.

Authors:  H J Gallowitsch; J Sykora; P Mikosch; E Kresnik; O Unterweger; M Molnar; G Grimm; P Lind
Journal:  Eur J Nucl Med       Date:  1998-03

5.  Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation.

Authors:  Yasmin Masood; Yi-Hwa Liu; Gordon Depuey; Raymond Taillefer; Luis I Araujo; Steven Allen; Dominique Delbeke; Frank Anstett; Aharon Peretz; Mary-Jo Zito; Vera Tsatkin; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

6.  Clinical relevance of a normal myocardial perfusion scintigraphic study. American Society of Nuclear Cardiology.

Authors:  T M Bateman
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

7.  Improved coronary disease detection with quantitative attenuation-corrected Tl-201 images.

Authors:  Mathew Shotwell; Balkrishna M Singh; Charlotte Fortman; Brian D Bauman; Jennifer Lukes; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

8.  Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population.

Authors:  D A Calnon; P D McGrath; A L Doss; F E Harrell; D D Watson; G A Beller
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

9.  Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation.

Authors:  Amar D Patel; Wael S Abo-Auda; Jonathan M Davis; Gilbert J Zoghbi; Mark H Deierhoi; Jaekyeong Heo; Ami E Iskandrian
Journal:  Am J Cardiol       Date:  2003-07-15       Impact factor: 2.778

10.  Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing.

Authors:  Jose Jayme G De Lima; Emil Sabbaga; Marcelo Luis C Vieira; Flavio J de Paula; Luis E Ianhez; Eduardo M Krieger; Jose Antonio F Ramires
Journal:  Hypertension       Date:  2003-08-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.